|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV035237848 |
| 003 |
DE-627 |
| 005 |
20230625203618.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2016 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2016.05.005
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2016009000002.pica
|
| 035 |
|
|
|a (DE-627)ELV035237848
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(16)30026-2
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Casanova, Ludovic
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics
|
| 264 |
|
1 |
|c 2016transfer abstract
|
| 300 |
|
|
|a 9
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a • Many outcomes based on morbimortality have measured the seasonal influenza vaccine's effectiveness on patients with diabetes aged 65 and higher. • For working-age patients with diabetes, studies are rare and the effectiveness measured sometimes non significant for some outcomes. • Several biases restricted the demonstration of the seasonal influenza vaccine's effectiveness for patients with diabetes. • The residual confounding between vaccinated and non-vaccinated diabetics has been measured by analysing the persistence of a decrease of morbimortality other than during influenza season. • It would be interesting in future works to use this approach in order to test the effect of adjustment of the healthy vaccine bias.
|
| 520 |
|
|
|a • Many outcomes based on morbimortality have measured the seasonal influenza vaccine's effectiveness on patients with diabetes aged 65 and higher. • For working-age patients with diabetes, studies are rare and the effectiveness measured sometimes non significant for some outcomes. • Several biases restricted the demonstration of the seasonal influenza vaccine's effectiveness for patients with diabetes. • The residual confounding between vaccinated and non-vaccinated diabetics has been measured by analysing the persistence of a decrease of morbimortality other than during influenza season. • It would be interesting in future works to use this approach in order to test the effect of adjustment of the healthy vaccine bias.
|
| 650 |
|
7 |
|a Influenza vaccines
|2 Elsevier
|
| 650 |
|
7 |
|a Bias
|2 Elsevier
|
| 650 |
|
7 |
|a Diabetes mellitus
|2 Elsevier
|
| 650 |
|
7 |
|a Influenza, Human
|2 Elsevier
|
| 700 |
1 |
|
|a Gobin, Nirvina
|4 oth
|
| 700 |
1 |
|
|a Villani, Patrick
|4 oth
|
| 700 |
1 |
|
|a Verger, Pierre
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:10
|g year:2016
|g number:6
|g pages:398-406
|g extent:9
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2016.05.005
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 10
|j 2016
|e 6
|h 398-406
|g 9
|
| 953 |
|
|
|2 045F
|a 610
|